Atrial Fibrillation

This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower  ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion

warfarin, long-term stability, atrial fibrillation, DCRI study, Sean Pokorney
News | Antiplatelet and Anticoagulation Therapies | August 16, 2016
August 16, 2016 — Warfarin prescribed to prevent strokes in atrial fibrillation may not adequately control blood...
Biosense Webster, Smarttouch SF, ablation catheter, AF, Afib, Atrial fibrillation treatment
Technology | Ablation Systems | August 15, 2016
August 15, 2016 — The U.S. Food and Drug Administration has granted market approval for the Biosense Webster Thermocool...
S-ICD, subcutaneous implantable cardioverter defibrillator, MRI safe ICD, Emblem
Technology | Implantable Cardioverter Defibrillator (ICD) | August 09, 2016
August 9, 2016 — The U.S. Food and Drug Administration (FDA) granted market approval for the Emblem MRI Subcutaneous...
Watchman, left atrial appendage closure, LAA occluder

An illustration of a Watchman transcatheter LAA occluder being implanted.

Feature | Left Atrial Appendage (LAA) Occluders | August 01, 2016 | Dave Fornell
Patients with atrial fibrillation (AF or Afib) are high risk for stroke due to the formation of thrombus emboli in the ...
Alere, INRatio PT/INR Monitor, voluntary recall, FDA
News | Blood Testing | July 12, 2016
July 12, 2016 — Following a collaborative process with the U.S. Food and Drug Administration (FDA), Alere Inc. will be...
pros and cons of new anticoagulation therapies, anticoagulants, dabigatran, Pradaxa, novel oral anticoagulants, NOACs, rivaroxaban, Xarelto, apixaban, Eliquis
Feature | Antiplatelet and Anticoagulation Therapies | July 26, 2016 | Heidi Olson, Pharm.D
With the recent introduction of several novel oral anticoagulants (NOACs) on the U.S. market that have been billed by...
Abbott, FIRM-guided rotor ablation, atrial fibrillation, clinical studies, Cardiostim 2016
News | EP Mapping and Imaging Systems | July 07, 2016
July 7, 2016 — Abbott recently announced positive results from three clinical studies investigating the benefits...
AtriCure, FROST cryoanalgesia study, William Beaumont Hospital Michigan, cryoICE system
News | Left Atrial Appendage (LAA) Occluders | July 07, 2016
July 7, 2016 — AtriCure Inc. announced the first patient has been enrolled in the FROST study at William Beaumont...
AtriCure, AtriClip PRO2 LAA Exclusion System, CE Mark, left atrial appendage occlusion
News | Left Atrial Appendage (LAA) Occluders | July 05, 2016
July 5, 2016 — AtriCure Inc. announced that it has received CE Mark for the AtriClip PRO2 Left Atrial Appendage (LAA)...
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Cardiovascular Clinical Studies | June 28, 2016
June 28, 2016 — New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom...
atrial fibrillation, stroke risk, aspirin vs blood thinners, JACC study
News | Antiplatelet and Anticoagulation Therapies | June 24, 2016
June 24, 2016 — More than 1 in 3 atrial fibrillation (AF) patients at intermediate to high risk for stroke are treated...
female patients, atrial fibrillation, blood thinning therapy, AFDST, decision support tool, Cincinnati
News | Antiplatelet and Anticoagulation Therapies | June 02, 2016
June 2, 2016 — Female atrial fibrillation patients are less likely than their male counterparts to receive blood...
anticoagulants, U.S. market, Technavio, 2020, trends
News | Antiplatelet and Anticoagulation Therapies | May 25, 2016
May 25, 2016 — Technavio’s latest report on the U.S. anticoagulants market provides an analysis on the most important...
Watchman, left atrial appendage closure, LAA occluder, LAA. LAAO, laa occluder, left atrial appendage, Watchman

The Boston Scientific Watchman device is currently the only transcatheter LAA occluder cleared for use in the United States.

Feature | Left Atrial Appendage (LAA) Occluders | May 20, 2016 | Dave Fornell
Atrial fibrillation (AF) affects nearly 6 million Americans and the condition puts them at significantly greater risk...
News | Atrial Fibrillation | May 19, 2016
May 19, 2016 — Physician-researchers in the College of Medicine at the University of Cincinnati have developed a...